Basilea Pharmaceutica AG (OTCMKTS:BPMUF – Get Free Report)’s share price hit a new 52-week high during trading on Tuesday . The company traded as high as $44.45 and last traded at $44.45, with a volume of 0 shares trading hands. The stock had previously closed at $44.45.
Basilea Pharmaceutica Price Performance
The business has a 50 day moving average of $40.99 and a 200 day moving average of $41.63.
About Basilea Pharmaceutica
Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.
Further Reading
- Five stocks we like better than Basilea Pharmaceutica
- 3 Fintech Stocks With Good 2021 Prospects
- Comprehensive PepsiCo Stock Analysis
- How to Find Undervalued Stocks
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- 3 Grocery Stocks That Are Proving They Are Still Essential
- 3 Steel Stocks Could Soar on New China Tariffs
Receive News & Ratings for Basilea Pharmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basilea Pharmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.
